CONTINEUM THERAPEUTICS INC-A (CTNM) Stock Analyst Earnings Estimates
NASDAQ:CTNM - Nasdaq - US21217B1008 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50M | -100.00% | 6.12M | -100.00% | ||||
| EBITDA YoY % growth | -28.322M | -22.391M 20.94% | 16.272M 172.67% | -47.375M -411.18% | -79.38M -56.77% | -111.159M -40.03% | -152.229M -36.95% | |
| EBIT YoY % growth | -28.647M | -22.72M 20.69% | 16.077M 170.76% | -48.276M -416.56% | -74.356M -46.10% | -100.889M -35.68% | -134.087M -32.91% | |
| Operating Margin | N/A | N/A | 32.15% | N/A | -1,214.97% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.95 | -2.55 48.03% | -2.89 -13.41% | -2.64 8.47% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.45 -15.08% | -0.64 -60.65% | -0.69 -23.34% | -0.66 -6.94% |
| Revenue Q2Q % growth | 10.2M | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -13.569M -23.99% | -20.164M -55.42% | -21.972M -28.89% | -24.786M -45.90% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.62 82.54% | -0.58 | -0.04 | -7.58% |
| Q4 2024 Q2Q % growth | -0.56 | -0.44 | -0.12 | -28.28% |
| Q3 2024 Q2Q % growth | -0.40 | -0.42 | 0.02 | 4.35% |
| Q2 2024 Q2Q % growth | -0.39 | -0.35 | -0.04 | -10.03% |
| Q1 2024 Q2Q % growth | -3.55 | -0.47 | -3.08 | -656.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 5% | -10.64% |
| Revenue | N/A | N/A | -20% | 20% |